Ablation Device Global Market

Forecast to 2023

Ablation Device Global Market estimated to be worth $20.9 billion by 2023

IQ4I Research & Consultancy published a new report on Ablation Device Global
Market Forecast To 2023 This report analyzes and studies the overall market, major
drivers & Opportunities, Restraints & Threats in North America, Europe, Asia-Pacific and
Rest of the World

IQ4Is Report Contains 112 market data tables and 61 figures spread through 365
pages and an exhaustive TOC on Ablation Device Global Market [TECHNIQUES
((Thermal (Cryoablation, Radiation, Radiofrequency, Laser, Microwave, Ultrasound &
Hydrothermal), Non-Thermal (Electroporation, Mechanical & Others)), APPLICATIONS
(Cancer, Cardiovascular (Atrial Fibrillation, Ventricular Tachycardia, Others)
Ophthalmology, Cosmetology, Gynecology, General Surgery, Urology, Orthopedics,
Pain Management & Others ), END-USERS (Hospitals, Ambulatory Surgical Centers &
Specialty Clinics), REGIONAL (North America (U.S., Others), Europe (U.K., Germany,
France, Others), Asia Pacific (India, China, Japan, Others) and Rest of the World
(Brazil, Middle East, Others))]

This report analyzes the ablation device global market in terms of market revenue ($ million)
for all segments and it enables ablation device stakeholders such as Ablation device
products manufacturers, distributors and wholesalers, OEM Manufacturers, Clinical
laboratories and hospitals, Various research and consulting firms, Contract manufacturing
organizations (CMOs), Group Purchasing Organizations (GPOs), Surgical device players to
identify and analyze market expansion opportunities, upcoming technologies and
competition in ablation device global market.

Ablation is a process of tissue removal by either minimally invasive procedures or through

surgical procedures using thermal or non thermal technologies. The procedures date to as
old as 1981, when the first catheter ablation was performed on humans for treating atrial
fibrillation. Since then ablation technology have grown over time and have emerged as more
sophisticated, easy to use next-generation devices for treating conditions such as cancer,
pain, epilepsy, eye disorders, cosmetic skin corrections, abnormal uterine bleeding,
hypertension, benign prostatic hyperplasia, Barrets oesophagus and asthma. Ablation
technology sorts are generally differentiated based on the type of energy utilized. These
include laser, radiation, radiofrequency, ultrasound, freeing cold temperature, chemical,
hydrothermal, microwave, and mechanical.

The ablation device global market is expected to grow at the high single digit CAGR due to
the increase in the incidence of cardiac diseases. According to IQ4I Analysis, the ablation
device global market is valued at $11,766.6 million in 2016 and is expected to reach

IQ4I Research & Consultancy Pvt. Ltd. Page 1

Ablation Device Global Market

Forecast to 2023

$20,995.5 million by 2023. Increasing number of ablation procedures, rising incidence of

cancer, an emergence of next-generation ablation products and technologies, growing
adoption of minimally invasive procedures, and improving reimbursement scenario in
established markets are some of the factors driving the market. However, reuse and
reprocessing of devices in developing countries, healthcare cost-containment measures,
stringent regulatory guidelines, and challenges in therapeutic procedures are some of the
factors hampering the market.

Ablation devices are categorized based on the technology or the modality that is used to
bring about ablation as thermal and non-thermal mode of ablation. Thermal technologies are
further segmented into radiofrequency, freezing cold temperatures (Cryoablation), laser,
microwave, radiation, ultrasound and hydrothermal energy. These ablation devices bring
about heating of the tissue by using any one of the energy source and ablate the tissue.
Non-thermal technologies include irreversible electroporation, mechanical and other modes
of ablation (Chemical). Radiofrequency ablation has been the established standard, but
cryoablation and microwave ablation technologies are soon set to out par the radiofrequency
market and indicate high growth potential.

Many hybrid technologies are entering the market, and are expected to have a great position
in future due to its dual mechanism capabilities. The Sonata (Sonography-Guided
Transcervical Fibroid Ablation) System by Gynesonics is an advanced technology platform
integrating miniaturized sonographic guidance with radiofrequency ablation in a single
delivery system for transcervical treatment of a wide range of uterine fibroid types and sizes.

By application, the market is segmented into oncology, cardiovascular (atrial fibrillation,

ventricular tachycardia, and others), ophthalmology, cosmetology, gynecology, urology,
orthopedics, pain management and others. While the various ablation techniques make
them flexible devices for use in an extensive variety of surgical methods, the highest
utilization is witnessed in cancer therapy for the removal of cancerous tissue, followed by
cardiovascular and then the general surgery applications. Similarly by end-users, the market
is segmented into hospitals, ambulatory surgical centers, and specialty clinics and increased
reimbursement facility is aiding for the growth of hospitals.

North America accounted for the largest share in the ablation device market and is estimated
at in 2016. The existence of well established healthcare infrastructures utilizing sophisticated
and advanced ablation technologies is responsible for high growth in this region. On the
other hand, Asia Pacific region is expected to grow high with a double digit CAGR by 2023.

IQ4I Research & Consultancy Pvt. Ltd. Page 2

Ablation Device Global Market

Forecast to 2023

The growth is attributed to increasing healthcare awareness among people for early
diagnosis and rising government expenditure on healthcare services.

The key players in the ablation device global market include Boston Scientific Corporation
(U.S.), Johnson and Johnson (U.S.), Abbott laboratories (St Jude Medical) (U.S.), Medtronic
(Ireland), Stryker Corporation (U.S.), Elekta AB (Sweden), Olympus Corporation (Japan),
ConMed Corporation (U.S.), Hologic (U.S.), Articure Inc. (U.S.), Angiodynamics Inc. (U.S.),
Smith and Nephew plc (U.K.), and Varian Medical Systems (U.S.).

Other key players in the market are Halyard Health (U.S.), BTG PLC (U.S.), Insightec
(Israel), EDAP Tms (France), SonaCare Medical (U.S) and Misonix (U.S.)

Reasons for buying this report:

Identification and analysis of the ablation device market segments by techniques,
applications, end-users and geography
Analysis of the global market by identifying various sub-segments of the ablation
device market
Revenue forecast of the ablation device global market and strategic analysis of each
submarket with respect to individual growth trends
Revenue forecast of the ablation device market with respect to North America (U.S.,
Others), Europe (U.K., Germany, France, Others), Asia-Pacific (India, China, Japan,
Others) and the Rest of the World (RoW) (Brazil, Middle East, Others) regions
Identification of the major market trends and factors driving or inhibiting the growth of
the ablation device global and its various sub-markets
Analysis of the opportunities for stakeholders by identifying the high-growth
segments of the market
Profiles of major players in the ablation device global market with details of their
product offerings, business strategies and SWOTs
Market shares for overall ablation device market, atrial fibrillation & radiation therapy,
market share for application by thermal technology, oncology types share, patent
analysis, upcoming technology, reimbursement, regulatory scenario, and supply
chain analysis, procedure volume, average selling price and procedural cost for each
technology
Established and Emerging players (109 companies) and their product offerings.

IQ4I Research & Consultancy Pvt. Ltd. Page 3

Ablation Device Global Market

Forecast to 2023

FIGURE 1

ABLATION DEVICE GLOBAL MARKET SEGMENTATION

Ablation Devices Global

Market

By Technology By Application By End Users

Thermal Non-Thermal
Cancer General Surgery Hospitals
technology technology
Ambulatory
Cryoablation Mechanical Ophthalmology Urology
Surgical Centers

Radiation Electroporation Cosmetology Pain Management Specialty Clinics

Radiofrequency Other Gynecology Orthopedics

Laser Cardiovascular Others

Ultrasound Atrial Fibrillation

Ventricular
Microwave
Tachycardia

Hydrothermal Others

IQ4I Research & Consultancy Pvt. Ltd. Page 4